Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Andrew Firlik
AddedMar 31, 2024
UpdatedMay 31, 2026
Andrew Firlik

Andrew Firlik

Co-Founder, Jazz Venture Partners

CrunchbaseLinkedIn

Andrew Firlik's Career

Jazz Venture Partners
Jazz Venture Partners

San Francisco, CA, US

Co-Founder
Transoma Medical
Transoma Medical

Saint Paul, MN, US

Co-Founder
Vertos Medical
Vertos Medical

Aliso Viejo, CA, US

Board Member· Board
Thrive Global
Thrive Global

New York City, NY, US

Board Member· Board
Sopherion Therapeutics
Sopherion Therapeutics

East Brunswick, NJ, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Andrew Firlik's Career

Jazz Venture Partners
Jazz Venture Partners
Investment FirmInvestment Firm262015San Francisco, CA, US
Co-Founder

Leadership at Jazz Venture Partners

John SpinaleJohn SpinaleCo-Founder
Zack LynchZack LynchCo-Founder
Adam GazzaleyAdam GazzaleyCo-Founder

Similar to Jazz Venture Partners

Beat VenturesBeat VenturesSan Francisco, CA, USest. 2021Beat VenturesSan Francisco, CA, US · est. 2021

San Francisco-based financial services investing in people-centered tech for the future of work.

Investment Firm2
Next VentūresNext VentūresSan Francisco, CA, USest. 2018Next VentūresSan Francisco, CA, US · est. 2018

NEXT VENTŪRES: A venture capital firm specializing in sports, fitness, nutrition, and wellness markets.

Investment Firm12
Digitalis VenturesDigitalis VenturesNew York City, NY, USest. 2016Digitalis VenturesNew York City, NY, US · est. 2016

Digitalis: A venture capital firm investing in innovative solutions for human and animal health.

Investment Firm19
Boutique Venture PartnersBoutique Venture PartnersPalo Alto, CA, USest. 2020Boutique Venture PartnersPalo Alto, CA, US · est. 2020

Boutique Venture Partners: A healthcare-focused VC firm, leveraging deep industry connections to back innovative, high-impact startups.

Investment Firm8
Transoma Medical
Transoma Medical
Acquired$42.7M02008Saint Paul, MN, US
Co-Founder

Leadership at Transoma Medical

Brian BrockwayBrian BrockwayCo-Founder
Dr K James EhlenDr K James EhlenBoard Member

Similar to Transoma Medical

CardiomemsCardiomemsAtlanta, GA, USMedical Devicesest. 2001CardiomemsAtlanta, GA, US · est. 2001

CardioMEMS: Innovating wireless medical devices for managing severe cardiovascular diseases.

Public · $232.6M175
Concept MedicalConcept MedicalTampa, FL, USMedical Devicesest. 2008Concept MedicalTampa, FL, US · est. 2008

Concept Medical: Innovating treatments for coronary and peripheral artery diseases with advanced medical devices.

Series D · $60M234
Transverse MedicalTransverse MedicalGolden, CO, USMedical Devicesest. 2011Transverse MedicalGolden, CO, US · est. 2011

Transverse Medical: Innovating cerebral protection with dynamic heart valve solutions to prevent strokes.

Series A · $6.6M6
Vertos Medical
Vertos Medical
Series C$177.8M1632005Aliso Viejo, CA, US
Board Member· Board

Leadership at Vertos Medical

Don SchomerDon SchomerCo-Founder
Eric WichemsEric WichemsCEO
Dave SolsbergDave SolsbergCo-Founder
Hugo HarrodHugo HarrodBoard Member
Ittai HarelIttai HarelBoard Member
Mike BoggsMike BoggsBoard Member

Similar to Vertos Medical

Vertebral TechnologiesVertebral TechnologiesMinnetonka, MN, USMedical Devicesest. 2005Vertebral TechnologiesMinnetonka, MN, US · est. 2005

Vertebral Technologies: Innovating implantable spinal devices for advanced medical solutions.

Series B · $8.6M25
VerteCoreVerteCoreJackson, MS, USMedical Devicesest. 2015VerteCoreJackson, MS, US · est. 2015

VerteCore Technologies designs innovative, non-surgical devices for spinal disorders, offering cost-effective back pain relief and reducing the need for hospitalization.

Seed · $182.5k30
Spinal SimplicitySpinal SimplicityOverland Park, KS, USMedical Devicesest. 2008Spinal SimplicityOverland Park, KS, US · est. 2008

Medical device firm, Spinal Simplicity, innovates minimally invasive solutions for complex spinal issues.

Series D · $37.8M70
Thrive Global
Thrive Global
Series C$145.9M9562016New York City, NY, US
Board Member· Board

Recent news

InScope nabs $14.5M to solve the pain of financial reportingTechCrunch · 2026
Hear from Sequoia Capital and Kleiner Perkins this week on TechCrunch LiveTechCrunch · 2023

Leadership at Thrive Global

Arianna HuffingtonArianna HuffingtonFounder
Somesh DashSomesh DashBoard Member
Lloyd MinorLloyd MinorBoard Member
Paul HsiaoPaul HsiaoBoard Member
Fred HarmanFred HarmanBoard Member
David AgusDavid AgusBoard Member

Similar to Thrive Global

ThriveStreamsThriveStreamsNew York City, NY, USSoftwareest. 2012ThriveStreamsNew York City, NY, US · est. 2012

ThriveStreams: Innovating in Positive Technology to empower human potential and wellbeing.

Seed · $20k5
Thrive SoftwareThrive SoftwareBaltimore, MD, USSoftware Solutionsest. 2018Thrive SoftwareBaltimore, MD, US · est. 2018

Thrive Software: Developing efficient, impactful software solutions, founded by innovative leaders.

Seed · $900k7
Sopherion Therapeutics
Sopherion Therapeutics
Acquired$163M02001East Brunswick, NJ, US
Co-Founder

Leadership at Sopherion Therapeutics

David I ScheerDavid I ScheerCo-Founder
Dr Joyce TsangDr Joyce TsangBoard Member
Peter ErnsterPeter ErnsterBoard Member

Similar to Sopherion Therapeutics

Sutro BiopharmaSutro BiopharmaSouth San Francisco, CA, USCancer Therapeuticsest. 2003Sutro BiopharmaSouth San Francisco, CA, US · est. 2003

Sutro Biopharma, a California-based medical firm, develops and manufactures cancer therapy drugs.

Public · $561.6M278
SphynKx TherapeuticsSphynKx TherapeuticsCharlottesville, VA, USBiotechnology, Therapiesest. 2010SphynKx TherapeuticsCharlottesville, VA, US · est. 2010

SphynKx Therapeutics: Innovating biotech solutions for cancer and fibrosis treatment.

Seed · $50k30

Andrew Firlik's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Andrew Firlik

Zachary HillZachary HillCo-Founder · Soteria BiotherapeuticsAlexander MartinkoAlexander MartinkoCo-Founder · Soteria BiotherapeuticsAndrew TsourkasAndrew TsourkasCo-Founder · SonoSolveFabio SerenelliFabio SerenelliCo-Founder · Sofia LabsRohit AgarwalRohit AgarwalCo-Founder · SoraJevgenij WernerJevgenij WernerCo-Founder · Sofia Labs